Concepts (73)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Amino Acids, Aromatic | 1 | 2021 | 36 | 0.770 |
Why?
|
Leukemia Virus, Murine | 1 | 2021 | 94 | 0.760 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2017 | 113 | 0.530 |
Why?
|
Viral Nonstructural Proteins | 1 | 2017 | 223 | 0.510 |
Why?
|
Cell Membrane | 3 | 2023 | 3680 | 0.450 |
Why?
|
Virus Internalization | 3 | 2022 | 494 | 0.440 |
Why?
|
HIV-1 | 4 | 2024 | 6850 | 0.410 |
Why?
|
Membrane Fusion | 2 | 2022 | 266 | 0.350 |
Why?
|
Influenza Vaccines | 1 | 2017 | 759 | 0.340 |
Why?
|
Membrane Proteins | 3 | 2023 | 7843 | 0.320 |
Why?
|
Immune Sera | 3 | 2023 | 613 | 0.300 |
Why?
|
Influenza, Human | 1 | 2017 | 1516 | 0.260 |
Why?
|
Mutation | 7 | 2022 | 29915 | 0.240 |
Why?
|
HIV Infections | 5 | 2024 | 17275 | 0.230 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 2 | 2023 | 148 | 0.230 |
Why?
|
Virulence | 3 | 2022 | 1298 | 0.220 |
Why?
|
Antibodies, Neutralizing | 4 | 2024 | 1931 | 0.190 |
Why?
|
Immunization, Secondary | 1 | 2024 | 368 | 0.190 |
Why?
|
Virus Latency | 1 | 2024 | 362 | 0.180 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2023 | 368 | 0.180 |
Why?
|
Antibodies, Viral | 4 | 2024 | 3142 | 0.170 |
Why?
|
Nucleotides | 1 | 2022 | 450 | 0.170 |
Why?
|
Serine Endopeptidases | 2 | 2022 | 1020 | 0.170 |
Why?
|
Amino Acid Substitution | 1 | 2022 | 1734 | 0.150 |
Why?
|
Viremia | 1 | 2020 | 706 | 0.150 |
Why?
|
Amino Acids | 1 | 2022 | 1713 | 0.130 |
Why?
|
Immunity, Cellular | 1 | 2021 | 1557 | 0.120 |
Why?
|
Cell Wall | 1 | 2017 | 425 | 0.110 |
Why?
|
Virus Replication | 4 | 2022 | 2430 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1444 | 0.100 |
Why?
|
HEK293 Cells | 1 | 2021 | 4257 | 0.100 |
Why?
|
Cell Line | 3 | 2022 | 15591 | 0.050 |
Why?
|
Luminescence | 1 | 2023 | 108 | 0.050 |
Why?
|
Mesocricetus | 1 | 2022 | 252 | 0.050 |
Why?
|
Convalescence | 1 | 2022 | 106 | 0.050 |
Why?
|
Humans | 13 | 2024 | 758406 | 0.050 |
Why?
|
Vaccination | 2 | 2024 | 3355 | 0.050 |
Why?
|
Tissue Culture Techniques | 1 | 2022 | 290 | 0.050 |
Why?
|
Japan | 1 | 2024 | 1366 | 0.040 |
Why?
|
Binding, Competitive | 1 | 2021 | 1141 | 0.040 |
Why?
|
HLA-B Antigens | 1 | 2020 | 331 | 0.040 |
Why?
|
Tanzania | 1 | 2023 | 1383 | 0.040 |
Why?
|
Protein Binding | 2 | 2021 | 9311 | 0.040 |
Why?
|
Nasal Mucosa | 1 | 2022 | 412 | 0.040 |
Why?
|
Cricetinae | 1 | 2022 | 2426 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2569 | 0.040 |
Why?
|
Genome, Viral | 1 | 2021 | 658 | 0.040 |
Why?
|
Receptors, Virus | 1 | 2021 | 639 | 0.040 |
Why?
|
Immune Evasion | 1 | 2020 | 362 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2023 | 1986 | 0.030 |
Why?
|
South Africa | 1 | 2022 | 1821 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2502 | 0.030 |
Why?
|
Viral Proteins | 1 | 2021 | 1801 | 0.030 |
Why?
|
Phylogeny | 1 | 2021 | 2774 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2020 | 1826 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2022 | 2532 | 0.030 |
Why?
|
Lung | 2 | 2022 | 9985 | 0.030 |
Why?
|
Intestines | 1 | 2022 | 1906 | 0.030 |
Why?
|
Animals | 3 | 2022 | 167768 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3321 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2024 | 4353 | 0.020 |
Why?
|
Models, Molecular | 1 | 2021 | 5410 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2022 | 3056 | 0.020 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3705 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4549 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2020 | 18940 | 0.020 |
Why?
|
Pandemics | 1 | 2021 | 8611 | 0.010 |
Why?
|
Male | 3 | 2024 | 358747 | 0.010 |
Why?
|
Aged | 2 | 2024 | 168218 | 0.010 |
Why?
|
Middle Aged | 2 | 2024 | 219568 | 0.010 |
Why?
|
Adult | 2 | 2024 | 219935 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2022 | 58683 | 0.010 |
Why?
|
Female | 2 | 2024 | 390323 | 0.010 |
Why?
|
Concepts
(73)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_